A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL.

Autor: Isaksen KT; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Mastroianni MA; Department of Hematology, Akershus University Hospital, Lørenskog, Norway., Rinde M; Department of Hematology, Vestfold Hospital Trust, Tønsberg, Norway., Rusten LS; Section of Oncology, Department of Surgery, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway., Barzenje DA; Department of Oncology, Østfold Hospital Trust, Kalnes, Norway., Ramslien LF; Department of Hematology, Telemark Hospital Trust, Skien, Norway., Slaaen M; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; The Cancer Unit, Hamar Hospital, Innlandet Hospital Trust, Hamar, Norway., Jerm MB; Cancer Registry of Norway, Department of Registration, Oslo, Norway., Smeland EB; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Rostoft S; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway., Liestøl K; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.; Department of Informatics, University of Oslo, Oslo, Norway; and., Brodtkorb M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Holte H; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.

Publikováno v: Blood advances [Blood Adv] 2021 Nov 23; Vol. 5 (22), pp. 4771-4782.

Autor: Barzenje DA

Publikováno v: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2018 Jan 08; Vol. 138 (1). Date of Electronic Publication: 2018 Jan 08 (Print Publication: 2018).

Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years.

Autor: Barzenje DA; Department of Oncology, Ostfold Hospital Trust, Fredrikstad, Norway., Cvancarova Småstuen M; Department of Biostatistics, Oslo University Hospital, Oslo, Norway., Liestøl K; Center for Cancer Biomedicine, University of Oslo, Oslo, Norway; Department of informatics, University of Oslo, Oslo, Norway., Fosså A; Department of Oncology, Oslo University Hospital, Oslo, Norway., Delabie J; Department of Pathology, Oslo University Hospital, Oslo, Norway., Kolstad A; Department of Oncology, Oslo University Hospital, Oslo, Norway., Holte H; Department of Oncology, Oslo University Hospital, Oslo, Norway.

Publikováno v: PloS one [PLoS One] 2015 Jul 06; Vol. 10 (7), pp. e0131158. Date of Electronic Publication: 2015 Jul 06 (Print Publication: 2015).